Abstract
Chronic lymphedema is fraught with morbidity, including tissue loss. We present the case of a woman with long-standing lymphedema suffering from nonhealing ulcerations despite multiple interventions, who underwent below-knee amputation. Surgical pathology yielded a diagnosis of invasive squamous cell carcinoma. We highlight the uncommon association between lymphedema and squamous cell carcinoma, and the importance of routine pathological testing with lower extremity amputations.
Keywords: Squamous cell carcinoma, Chronic lymphedema, Amputation
Primary vascular disease accounts for the majority of nontraumatic lower extremity amputations.1 In the diabetic population, an estimated 120,000 lower extremity amputations are performed annually in the United States. A subset of that population, approximately 1.3 in 1000, are major amputations, defined as amputations above the ankle, performed in the context of nonhealing ulcerations.2 A neuroischemic etiology is prevalent in nonhealing ulcers,3 whereas chronic lymphedema is an uncommon cause of ulceration necessitating amputation. Furthermore, squamous cell carcinoma (SCC) arising from chronic lymphedema is exceedingly rare, with fewer than 20 cases reported in the literature, and only 11 involving a lower extremity.4 We present a case of SCC of the lower extremity, initially diagnosed as lymphedema, with definitive diagnosis after amputation performed for the nonhealing ulceration. Informed consent for publication was obtained from the patient.
Case report
A female in her 70s was referred to vascular surgery for bilateral lower extremity wounds present for more than 50 years. She had a previous medical history of lymphedema praecox and is a former smoker. The most significant wound involved full-thickness ulceration of the dorsal aspect of her ankle. Prior treatment attempts during the preceding 4 years at the referring practice included successful sclerotherapy of refluxing varicosities adjacent to the wound, with follow-up venous studies revealing reflux of the femoral and popliteal veins without residual varicosities of the lower leg. Additional prior workup included arterial studies with no arterial insufficiency. Her wounds persisted despite aggressive wound care and negative pressure therapy, as well as surgical debridement and skin grafting. No record of previously submitted surgical pathology samples, if any, was available. After these interventions failed, a below-knee amputation was recommended by her primary surgeon. She presented to our vascular surgery clinic for a second opinion. Unfortunately, given the extent of wounds and persistence despite extensive attempts at limb salvage, only major amputation was offered. She underwent an elective below-knee amputation in the standard fashion using a long posterior flap that was free from skin changes. Of note, significant edematous tissue was encountered intraoperatively; the tissue was otherwise unremarkable on gross examination. Following an uneventful postoperative course, she was discharged to an inpatient rehabilitation facility.
The specimen was sent, per our protocol, for gross pathology. After the patient's discharge from the hospital, the pathology report yielded evidence of SCC of the right ankle wound, with greater than 8 cm of tumor-free margin. She was referred to medical and surgical oncology, and an outpatient workup of her malignancy was initiated.
At 1 month postoperatively her incision was well-healed and the staples were removed. Oncologic workup included a positron emission tomography and bone scintigraphy scanning, which revealed a left lung mass, concerning for metastasis, as well as left inguinal lymphadenopathy, thought to be either metastatic or reactive in nature. Unfortunately, she returned to the clinic 2 months postoperatively with posterior knee swelling with associated permanent contracture of the knee joint. With concern for locoregional spread, the posterior knee mass was aspirated by interventional radiology, but found to be synovial and nonmalignant in nature. Nonetheless, the site of aspiration did not heal, and continued to produce seropurulent drainage over the following weeks. Given her significant discomfort, contracture, and nonhealing draining wound, a revision to an above-knee amputation was offered. After discussions with her family and with the palliative medicine service, inpatient hospice was eventually pursued.
Discussion
Chronic lymphedema is a prevalent and morbid condition, affecting up to 5 million individuals in the United States.5 Primary lymphedema, which is congenital in nature, is less common than the secondary phenotype, which most typically results after surgery, infection, malignancy, and/or radiation.6 Chronic lymphedema can result in significant tissue loss in the absence of peripheral arterial occlusive disease. Unfortunately, owing to the relative paucity of lymphedema-related lower extremity wounds, the literature pertaining to clinical description, classification, and treatment is inconsistent and limited.7 Ulceration in the context of lymphedema and concomitant SCC, as in this patient's case, is further complicated with even less available literature regarding its management.
Because lymphatic circulation is necessary for competent immune surveillance, maladaptive changes in the lymphatic system have been implicated in immunologic vulnerability and, in some cases, oncogenesis. Malignant transformation, such as Kaposi sarcoma and lymphangiosarcoma have been described as a result of lymphedema.8 Chronic lymphedema is associated with a small number of other cutaneous malignancies, including SCC, basal cell carcinoma, melanoma, Merkel cell carcinoma,9 extraosseous Ewing sarcoma,10 and diffuse large B-cell lymphoma.11 Lymphangiosarcoma resulting as a complication of long-standing lymphedema, also known as Stewart-Treves syndrome, is typically seen in the upper extremity after mastectomy and lymph node removal.12
Although there are reported instances of lymphedema and malignancies, cutaneous SCC as a result of lymphedema is exceedingly rare. In general, there are approximately 250,000 cases of cutaneous SCC in the United States annually, making it the second most common cancer. Of these cases, approximately 14% occur in the upper and lower limbs. The insults that cause this dysregulation of cell growth can be ultraviolet radiation, infection in the case of human papilloma virus, or, pertinent to our case, chronic wounds.13 A subset of cutaneous SCCs, Marjolin's ulcers, refers to SCC that arises in the context of chronic inflammation and/or in the presence of scar tissue, often seen after a burn, surgery, or an inflammatory skin condition. Our patient, however, was diagnosed with lymphedema praecox, a congenital pathological etiology of lymphedema. Moreover, she had no history of burns or prior surgical interventions, other than an attempted skin grafting on the left lower extremity.
Chronic venous insufficiency has been associated independently with malignant transformation. In a prospective study,14 10.4% of patients with chronic venous ulcers that did not heal despite appropriate standard treatment for 3 months yielded malignancy on biopsy (56% SCC). In this light, concomitant chronic venous insufficiency and lymphedema, termed phlebolymphedema with a chronic, nonhealing ulceration should heighten suspicion for malignant transformation and lead to biopsy early in the clinical course for timely diagnosis and potentially result in limb salvage.
To date, 11 cases of SCC of a lower extremity affected by lymphedema have been reported (Table).4,15, 16, 17, 18, 19, 20, 21, 22, 23 A congenital etiology of lymphedema was most common (36%), followed by post-traumatic (27%) and postfilarial (18%). The majority of these cases (64%) were treated with local excision with or without skin grafting of the defect.4,16, 17, 18, 19, 20 Pedal amputation was required in a case of SCC in a patient with lymphedema and underlying epidermodysplasia verruciformis, with extensive involvement of the distal foot.21 Above-the-knee amputation was required in a case of postfilarial lymphedema and SCC presenting with multiple ulcerations and wet gangrene who had been nonambulatory before presentation,15 as well as in a case of nonhealing ulcers of the foot with long-standing lymphedema nonresponsive to multiple treatments.22 One case15 received postoperative locoregional radiation therapy owing to spread to the inguinal lymph nodes. Chemotherapy was not used in any of these cases, likely owing to the nonmetastatic nature of the remaining reported cases. Follow-up information is only reported in 5 of the 11 cases. One patient expired 4 days postoperatively from a pulmonary embolism. The remaining cases with follow-up data were alive without recurrence at 1 to 60 months.4,16,19,20 Given the spectrum of treatments used in these cases, multiple factors need to be taken into account in determining appropriate therapy. Major amputation, as in our case and those described in the literature, should be considered based on ambulatory status, the number, severity, and nonhealing nature of wounds, and the patient's long-term goals.
Table.
Literature review of lymphedema-related squamous cell carcinoma (SCC) of the lower extremity
| Authors | Anatomy | Presentation | Etiology | Treatment |
|---|---|---|---|---|
| Epstein and Mendelsohn (1984)22 | Foot | Proliferative lesion | Congenital lymphedema | Above-knee amputation |
| Ostrow et al (1987)21 | Foot, groin | Ulcerative lesions | Congenital lymphatic dysplasia | Pedal amputation |
| Lister et al (1994)18 | Lower leg | Ulcerative lesion | Trauma-related lymphedema | Local excision |
| Lower leg | Proliferative lesion | Idiopathic | Local excision | |
| Echenique-Elizondo and Florza (2002)17 | Lower leg | Ulcerative lesion | Congenital lymphedema | Local excision |
| Furukawa et al (2002)19 | Lower leg | Ulcerative lesion | Post-hysterectomy lymphedema | Local excision |
| Bilen et al (2003)20 | Foot | Ulcerative lesion | Trauma-related lymphedema | Local excision |
| Gomes et al (2010)16 | Leg, unspecified | Proliferative lesion | Trauma-related lymphedema | Local excision |
| Kumar et al (2013)15 | Lower leg & foot | Ulcerative lesions | Filarial lymphedema | Above-knee amputation |
| Parthiban et al (2013)23 | Lower leg | Ulcerative lesions | Congenital lymphedema | Not specified |
| Gulati et al (2022)4 | Lower leg | Ulceroproliferative lesion | Filarial lymphedema | Local excision |
This case also highlights the importance of histopathological sampling for lower extremity amputations. Although the majority of nonhealing ulcers of the lower extremity are secondary to common clinical entities including arterial or venous insufficiency, diabetic vascular complications, and pressure ulceration, malignancy should remain an important consideration given its morbidity and complexity in further management. Incidentally found SCC after lower extremity amputation has been reported previously—one in a case of chronic venous stasis24 and another after hemipelvectomy for pelvic osteomyelitis.25 Last, it is possible that gross samples of preamputation surgical debridement could have yielded the diagnosis of SCC at an earlier stage in this patient's clinical course, although it is unclear if it would have made a difference in her outcome. As such, it is important, for the nonhealing wound, that all tissue removed intraoperatively, whether during major amputation or local debridement, be sent for pathological analysis.
Conclusions
We report the case of a postoperative diagnosis of SCC after a below-knee amputation for primary lymphedema. Although nonhealing lower extremity wounds are common indications for lower extremity amputations, routine histopathological testing should be performed, because it may have important clinical implications, as it did in this case.
Footnotes
Author conflict of interest: none.
The editors and reviewers of this article have no relevant financial relationships to disclose per the Journal policy that requires reviewers to decline review of any manuscript for which they may have a conflict of interest.
References
- 1.Gabel J., Jabo B., Patel S., Kiang S., Bianchi C., Chiriano J., et al. Analysis of patients undergoing major lower extremity amputation in the vascular quality initiative. Ann Vasc Surg. 2018;46:75–82. doi: 10.1016/j.avsg.2017.07.034. [DOI] [PubMed] [Google Scholar]
- 2.Geiss L.S., Li Y., Hora I., Albright A., Rolka K., Gregg E.W. Resurgence of diabetes-related nontraumatic lower-extremity amputation in the young and middle-aged adult U.S. Population. Diabetes Care. 1986;42:50–54. doi: 10.2337/dc18-1380. [DOI] [PubMed] [Google Scholar]
- 3.Mills J.L., Conte M.S., Armstrong D.G., Pomposelli F.B., Schanzer A., Sidawy A.N., et al. The Society for vascular surgery lower extremity threatened limb classification system: risk stratification based on wound, ischemia, and foot infection (WIfI) J Vasc Surg. 2014;59:220–234. doi: 10.1016/j.jvs.2013.08.003. [DOI] [PubMed] [Google Scholar]
- 4.Gulati S., Chandrashekhara S.H., Bhoriwal S., Kose S.I. Chronic lymphoedema: a nidus for squamous cell carcinoma. BMJ Case Rep. 2022;15:e248543. doi: 10.1136/bcr-2021-248543. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Lawenda B.D., Mondry T.E., Johnstone P.A. Lymphedema: a primer on the identification and management of a chronic condition in oncologic treatment. CA Cancer J Clin. 2009;59:8–24. doi: 10.3322/caac.20001. [DOI] [PubMed] [Google Scholar]
- 6.Zuther E. In: Lymphedema management: the comprehensive guide for practitioners. Von Rohr M., editor. Thieme Medical Publishers, Inc; 2005. Pathology; pp. 45–99. [Google Scholar]
- 7.Fife C.E., Farrow W., Hebert A.A., Armer N.C., Stewart B.R., Cormier J.N., et al. Skin and wound care in lymphedema patients: a taxonomy, primer, and literature review. Adv Skin Wound Care. 2017;30:305–318. doi: 10.1097/01.ASW.0000520501.23702.82. [DOI] [PubMed] [Google Scholar]
- 8.Ruocco V., Schwartz R.A., Ruocco E. Lymphedema: an immunologically vulnerable site for development of neoplasms. J Am Acad Dermatol. 2002;47:124–127. doi: 10.1067/mjd.2002.120909. [DOI] [PubMed] [Google Scholar]
- 9.Lee R., Saardi K.M., Schwartz R.A. Lymphedema-related angiogenic tumors and other malignancies. Clin Dermatol. 2014;32:616–620. doi: 10.1016/j.clindermatol.2014.04.008. [DOI] [PubMed] [Google Scholar]
- 10.McArdle D.J., Nott L., Harle R., McArdle J.P. Extraosseous Ewing sarcoma arising in a chronically lymphedematous limb. J Vasc Surg Cases Innov Tech. 2018;4:210–215. doi: 10.1016/j.jvscit.2018.04.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.González-Vela M.C., González-López M.A., Val-Bernal J.F., Fernández-Llaca H. Cutaneous diffuse large B-cell lymphoma of the leg associated with chronic lymphedema. Int J Dermatol. 2008;47:174–177. doi: 10.1111/j.1365-4632.2008.03375.x. [DOI] [PubMed] [Google Scholar]
- 12.Young R.J., Brown N.J., Reed M.W., Hughes D., Woll P.J. Angiosarcoma. Lancet Oncol. 2010;11:983–991. doi: 10.1016/S1470-2045(10)70023-1. [DOI] [PubMed] [Google Scholar]
- 13.Ratushny V., Gober M.D., Hick R., Ridky T.W., Seykora J.T. From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma. J Clin Invest. 2012;122:464–472. doi: 10.1172/JCI57415. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Senet P., Combemale P., Debure C., Baudot N., Machet L., Aout M., et al. Malignancy and chronic leg ulcers: the value of systematic wound biopsies: a prospective, multicenter, cross-sectional study. Arch Dermatol. 2012;148:704–708. doi: 10.1001/archdermatol.2011.3362. [DOI] [PubMed] [Google Scholar]
- 15.Kumar S., Gautam S., Mittal S., Mishra A.K. Squamous cell carcinoma in background of chronic lymphedema secondary to filariasis: a rare entity. J Case Rep. 2013;3:469–471. [Google Scholar]
- 16.Gomes C.A., Magalhaes C.B., Soares C., Peixoto R. Squamous cell carcinoma arising from chronic lymphedema: case report and review of the literature. Sao Paulo Med J. 2010;128:142–144. doi: 10.1590/S1516-31802010000100009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Echenique-Elizondo M., Elorza J. Squamous-cell carcinoma on long-lasting lymphoedema. Lancet Oncol. 2002;3:319. doi: 10.1016/s1470-2045(02)00734-9. [DOI] [PubMed] [Google Scholar]
- 18.Lister R.K., Black M.M., Calonje E., Burnand K.G. Squamous cell carcinoma arising in chronic lymphoedema. Br J Dermatol. 1997;136:384–387. [PubMed] [Google Scholar]
- 19.Furukawa H., Yamamoto Y., Minakawa H., Sugihara T. Squamous cell carcinoma in chronic lymphedema: case report and review of the literature. Dermatol Surg. 2002;28:951–953. doi: 10.1046/j.1524-4725.2002.02075.x. [DOI] [PubMed] [Google Scholar]
- 20.Bilen B.T., Gurlek A., Alaybeyoglu N., Celik M., Aydin N.E. Epidermoid carcinoma arising in chronic lymphedema. Eur J Surg Oncol. 2003;29:697–698. doi: 10.1016/s0748-7983(03)00114-8. [DOI] [PubMed] [Google Scholar]
- 21.Ostrow R.S., Manias D., Mitchell A.J., Stawowy L., Faras A.J. Epidermodysplasia verruciformis: a case associated with primary lymphatic dysplasia, depressed cell-mediated immunity, and bowen’s disease containing human Papillomavirus 16 DNA. Arch Dermatol. 1987;123:1511–1516. doi: 10.1001/archderm.123.11.1511. [DOI] [PubMed] [Google Scholar]
- 22.Epstein J.I., Mendelsohn G. Squamous carcinoma of the foot arising in association with long-standing verrucous hyperplasia in a patient with congenital lymphedema. Cancer. 1984;54:943. doi: 10.1002/1097-0142(19840901)54:5<943::aid-cncr2820540534>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
- 23.Parthiban R., Kaler A.K., Shariff S., Sangeeta M. Squamous cell carcinoma arising from congenital lymphedema. SAGE Open Med Case Rep. 2013;1 doi: 10.1177/2050313X13496507. 2050313X13496507. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Eliassen A., Vandy F., McHugh J., Henke P.K. Marjolin’s ulcer in a patient with chronic venous stasis. Ann Vasc Surg. 2013;27:1182.e5–1182.e8. doi: 10.1016/j.avsg.2013.06.002. [DOI] [PubMed] [Google Scholar]
- 25.Lack W., McKinley T. Marjolin’s ulcer: incidental diagnosis of squamous cell carcinoma on hemipelvectomy for recalcitrant pelvic osteomyelitis. Iowa Orthop J. 2010;30:174–176. [PMC free article] [PubMed] [Google Scholar]
